Roche continues strong momentum with 7% growth (CER) in the first half of 2025 – full-year outlook confirmed. For more details on our performance, click here ➡️ https://xmrrwallet.com/cmx.pgo.roche.com/hfrli #RocheFinancialResults
关于我们
罗氏是全球制药和诊断领域的领导者，致力于通过推动科学进步，改善人类生活。结合了制药和诊断两大业务的独特优势，使罗氏集团成为个体化医疗的领导者，通过个体化医疗为每一位患者提供最具针对性的治疗方案。 作为全球领先的生物技术公司之一，罗氏在抗肿瘤、免疫、抗感染、眼科和中枢神经系统领域拥有一流的差异化药物。罗氏在全球体外诊断和基于组织的肿瘤诊断领域享有领导地位，同时也是糖尿病管理领域的先驱者。 自1896年成立以来，罗氏始终致力于不断探索更好的疾病预防、诊断和治疗方案，持续为社会做出贡献。同时，公司不遗余力地与有关的利益相关方开展合作，提升患者对于创新药物的可及性。 在世界卫生组织基本药物目录中，有32个罗氏开发的药品，包括用以挽救生命的抗生素、抗疟药和抗肿瘤药物。罗氏连续11年位列道琼斯指数（DJSI）制药、生物技术和生命科学领域可持续发展的全球领导者。 罗氏总部位于瑞士巴塞尔，业务遍及全球150多个国家。2019年，罗氏全球拥有员工97,735名，研发投资120亿美元，总销售额达629亿美元。美国基因泰克公司（Genentech）是罗氏集团的全资子公司。此外，罗氏也是日本中外制药株式会社（Chugai）的控股方。 更多关于罗氏集团的信息，请登陆罗氏全球网站 www.roche.com。 #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- 网站
-
http://xmrrwallet.com/cmx.pwww.roche.com/
罗氏公司的外部链接
- 所属行业
- 生物技术研究
- 规模
- 超过 10,001 人
- 总部
- Switzerland 🇨🇭
- 类型
- 上市公司
- 领域
- biotechnology、innovation、personalized healthcare、great place to work、diagnostics、pharmaceuticals、research、healthcare、personalised healthcare、diabetes care、genomics、healthcare technology、big data和Science
地点
罗氏公司员工
动态
-
A unique genetic blueprint — that's what we all have in common. Did you know it's possible to unlock the secrets hidden within our genome? Thanks to next-generation sequencing (NGS), scientists can now decode our genes. With NGS, they can understand why some people develop certain diseases, how to prevent them, and the best ways to treat them. Curious to learn more? Here are 5 fascinating things about NGS and how this technology is improving patient care around the world! https://xmrrwallet.com/cmx.plnkd.in/gBezdDqr #Genomics #NGS #MakeSpaceWithSBX #RocheSBX
-
Are you passionate about ophthalmology and innovation? Join the Ophtha Innovation Challenge (OIC) to tackle significant unmet needs in chronic retinal diseases like Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). Since these conditions are chronic and require continuing long-term treatment, there is a high potential for information gaps between patients, caregivers and doctors, which can negatively impact treatment journeys. Through this challenge, the Ophthalmology Network is seeking innovative solutions to close these gaps, enhance patient care, and optimise disease management. Join and contribute to groundbreaking improvements in ophthalmology care. Visit https://xmrrwallet.com/cmx.plnkd.in/div5h3qu to submit your proposal! This initiative is specifically tailored to engage only participants outside the US and UK. #Roche #RocheOIC #HealthcareInnovation #OphthaInnovationChallenge
-
What happens when young artists and scientists spend a week exploring the future together? We recently found out. From July 13–19, Roche Continents 2025 brought 40 exceptional minds to Arles, France, for a transformative week of dialogue, discovery and co-creation. This year's Futurescapes theme challenged participants to imagine what lies ahead—through the lens of sustainability, ethics, and the evolving human experience. In partnership with LUMA Arles, they moved between immersive workshops, intimate discussions, and unexpected collaborations, pushing the boundaries of how art and science can shape the world. The feedback was incredible: many called it "inspiring and life-changing," valuing the unique cross-disciplinary exchange and expressing a strong desire to stay connected and continue their collaboration. We leave inspired by their questions, their curiosity, and the connections forged across disciplines, cultures and perspectives. To everyone who took part: thank you for lighting the way forward. 👉 Learn more about the program: https://xmrrwallet.com/cmx.plnkd.in/gJ4eaJ8Q #RocheContinents2025 #Futurescapes #Art #Science #Innovation #RochePhilanthropy
-
-
罗氏公司转发了
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
A strong first half for Roche with Group sales growing by 7% at constant exchange rates! I am pleased to share that our positive momentum continued and confirm our full-year outlook. Over the past six months, we have made significant progress in our pipeline and advanced four potentially practice-changing therapies into the final phase of clinical development. Looking forward, in the second half of 2025, we expect to see results from a number of phase III trials in breast cancer, severe eye diseases and multiple sclerosis. In Diagnostics, we continue to bring our breakthrough innovations to customers and patients, including the launch of our blood test for early Alzheimer’s detection. Thanks to all our teams around the world for their dedication and passion! #Strategy #Innovation #WeAreRoche
-
罗氏公司转发了
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
A strong first half for Roche with Group sales growing by 7% at constant exchange rates! I am pleased to share that our positive momentum continued and confirm our full-year outlook. Over the past six months, we have made significant progress in our pipeline and advanced four potentially practice-changing therapies into the final phase of clinical development. Looking forward, in the second half of 2025, we expect to see results from a number of phase III trials in breast cancer, severe eye diseases and multiple sclerosis. In Diagnostics, we continue to bring our breakthrough innovations to customers and patients, including the launch of our blood test for early Alzheimer’s detection. Thanks to all our teams around the world for their dedication and passion! #Strategy #Innovation #WeAreRoche
-
As populations age and diabetes rates rise across Asia Pacific, the risk of preventable vision loss is increasing – placing pressure on individuals, families, and health systems. That's why APVRS and Roche joined forces to host the “Turning Insights into Action: Advancing Vision Health in Asia Pacific” webinar – a multi-stakeholder discussion focused on strengthening early detection, timely treatment, and integrated vision care across the region. Drawing on findings from the APAC Vision Health Survey, experts shared lived experiences and perspectives from diverse healthcare settings, highlighting the importance of collaborative approaches to protecting vision and improving outcomes. Watch the full discussion here: https://xmrrwallet.com/cmx.plnkd.in/ek3K2Ah3 #APVRS #APACVisionHealthSurvey #RocheOphthaAPAC #RocheOphthalmology Andrew Chang Mårten Brelén Nor Fariza Ngah Paisan Ruamviboonsuk Prof Seung Young Yu Ahmed Elhusseiny
-
Mass spectrometry has the potential to provide patients with more personalised diagnoses. But do you know what makes this technology a gold standard in clinical diagnostic testing? #massspectrometry #innovation #diagnostics #RocheMassSpec
此处无法显示此内容
在领英 APP 中访问此内容等
-
Graduation season is a truly meaningful moment at Roche - seeing our talent grow and step into what’s next is inspiring. Together with our CEO Thomas Schinecker, we’re proud to celebrate 44 apprentices as they begin a new chapter. Join us in celebrating new beginnings, ongoing growth and staying curious. #WeAreRoche #GrowthMindset #EarlyCareers #Career
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
Just as the UEFA Women's EURO 2025 kicked off here in Switzerland, we were celebrating another kind of kickoff: a new chapter in many professional journeys. Last week, I joined 44 Roche apprentices to celebrate their graduation. Moments like these are among the most meaningful in any career – because they remind us where it all begins. I told our graduates: You don’t need to have it all mapped out. But one thing is clear – there are no shortcuts in life. If you want to achieve something, the only way to get there is through hard work and dedication. Football is a good reminder of many things: Teamwork matters. Preparation matters. Continuous learning and improvement matters. Last but not least, as a famous coach once said: “Nach dem Spiel ist vor dem Spiel.” In life – just like in football – you can’t rest on past successes. There’s always a next challenge. At Roche, we are investing in the next generation. Not just because it’s the right thing to do, but because we learn from them, too. They challenge how we do things. And they remind us to stay curious. More than half of this year’s apprentices will stay on at Roche – some as employees, others as students. That says a lot. About them, and about the people who guided them along the way. To all those finishing their training this summer – and to everyone who supported them: Congratulations – and thank you. Enjoy the moment!
-
-
What happens when young artists and scientists team up to build the future? 💡 We're about to find out! Next week, between July 13 and 19, Roche Continents 2025 brings together 40 of Europe’s brightest young minds to Arles, France, for a week of intense exploration and innovation. For over a decade, this program has united students from science and the arts to uncover where transformative ideas truly come from. This year's "Futurescapes" theme will challenge them to focus on sustainable development, ethical considerations, and the human experience within an evolving world. In partnership with LUMA Arles, participants will dive into hands-on workshops and interdisciplinary collaboration, creating solutions that drive positive change. Learn more about how we're empowering young minds to shape the future: https://xmrrwallet.com/cmx.plnkd.in/dEa4K9ZV #RocheContinents2025 #Futurescapes #Art #Science #Innovation